Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA gyrase is an essential bacterial enzyme classified as a type II topoisomerase. Its primary function is to introduce negative supercoils into double-stranded closed-circular DNA in an ATP-dependent manner. This activity is crucial for maintaining the proper topology of bacterial DNA, which facilitates processes such as replication and transcription by relieving torsional strain generated during these events. It is a validated antibacterial target.
Inhibition of DNA gyrase activity by blocking strand cleavage/religation or ATP binding/hydrolysis, leading to accumulation of double-strand breaks and/or failure to resolve topological stress during replication/transcription.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Gyrase.